Stamford, CT, United States of America

Nathan Katz

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nathan Katz: Innovator in Gene Therapy

Introduction

Nathan Katz, residing in Stamford, CT, is a distinguished inventor with a focus on innovative solutions in the field of gene therapy. He holds three patents to his name, demonstrating his commitment to advancing medical science and improving treatment options for various genetic disorders.

Latest Patents

One of Nathan's significant contributions to the medical field is his patented method for treating Batten disease, a severe neurodegenerative disorder. His latest patent provides methods and compositions that utilize a recombinant adeno-associated virus (rAAV) containing essential components such as an AAV capsid and a vector genome. This composition includes a 5' inverted terminal repeat sequence, a promoter, and a coding sequence for a human TPP1, all critical for effective treatment.

In addition to his work on Batten disease, Nathan has developed a patented composition useful in treating spinal muscular atrophy. This innovative rAAV vector employs an AAVhu68 capsid and incorporates nucleic acid sequences that encode a functional SMN protein. The expression control sequences direct the expression of these critical sequences in host cells, providing a promising therapy for patients suffering from this debilitating condition.

Career Highlights

Nathan has collaborated with prominent academic institutions, including the University of Pennsylvania, to expand his research and develop his groundbreaking therapies. His work has not only advanced scientific understanding but has also laid the groundwork for future innovations in the treatment of genetic disorders.

Collaborations

Throughout his career, Nathan Katz has worked alongside notable figures in the field. His collaborations with esteemed colleagues such as James M. Wilson and Christian Hinderer have further enhanced the quality and reach of his research, enabling the development of viable therapeutic applications for serious health conditions.

Conclusion

Nathan Katz exemplifies the spirit of innovation essential for addressing complex medical challenges. With his groundbreaking patents in gene therapy, he remains at the forefront of advancements that hold the potential to significantly improve patient outcomes and transform the medical landscape. His dedication to research and collaboration ensures that his contributions will have lasting impacts on the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…